XILAPLUS® / XILAPLUS® AF

4

Xyloglucan for the treatment of acute gastroenteritis in children: results of a randomized, controlled, clinical trial

Catalin Pleasea Condratovici, Vladimir C. Bacârea, Núria Piqué.

Gastroenterology Research and Practice. April 2016Background:Xyloglucan, a film-forming agent, improves intestinal mucosa resistance to pathologic damage. The efficacy, safety, and time of onset of the antidiarrheal effect of xyloglucan were assessed in children with acute gastroenteritis...

Read more

Let's meet in..

2021, Oct 05

Vitafoods

Read more

2021, Nov 09

CPhI 2021

Read more

2022, Feb 01

EWMA

Read more